{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:30:04Z","timestamp":1792416604500,"version":"4.4.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Xp11.2 translocation\/TFE3 gene fusion associated with renal cell carcinoma (Xp11.2 RCC) exhibits unique biological characteristics and is associated with an increased incidence of tumor thrombosis, lymph node metastasis, and advanced disease stages. Multimodality imaging, including US, contrast-enhanced CT, multi-parametric MRI, and <jats:sup>18<\/jats:sup>F-FDG PET\/CT plays a crucial role in the preoperative diagnosis and differentiation of renal tumors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case report<\/jats:title><jats:p>A 15-year-old female presented with lumbar pain worsened, and developed persistent painless hematuria. The CT attenuation values of the scan without contrast, corticomedullary phase, nephrographic phase, and delayed phases were 35 HU, 83 HU, 82 HU, and 75 HU, respectively. The solid component of the mass displayed heterogeneous marked enhancement. Furthermore, MRU indicated that the lesion involved the cortical medulla and infringed on the renal sinus fat. The lesion appeared isosignal in T1WI, slightly low signal in T2WI, and slightly high signal in DWI. The degree of enhancement in the three phases of enhancement scan was lower than that in the renal parenchyma, and hemorrhage and necrosis were observed within the internal part of the lesion. To further clarify the staging, the patient underwent <jats:sup>18<\/jats:sup>F-FDG PET\/CT. PET\/CT images showed multiple irregular occupancies in the right kidney with unclear borders, showing a heterogeneous increase in <jats:sup>18<\/jats:sup>F-FDG uptake, with SUVmax values ranging from 2.3 to 5.2 in the routine imaging phase (60\u2009min post-injection), compared to SUVmax values ranging from 2.8 to 6.9 in the delayed imaging phase (160\u2009min post-injection). Additionally, multiple enlarged and fused lymph nodes were observed in the medial part of the right kidney and the retroperitoneum, exhibiting a heterogeneous increase in <jats:sup>18<\/jats:sup>F-FDG uptake, with SUVmax values ranging from 4.1 to 8.7 in the routine imaging phase, compared to SUVmax values ranging from 4.4 to 9.1 in the delayed imaging phase. The postoperative pathology, immunohistochemistry, and molecular analysis of histiocytes were consistent with a diagnosis of Xp11.2 RCC. One month after surgery, enhanced-CT examination of the patient revealed lung metastasis, peritoneal metastasis, and multiple lymph node metastases throughout the body, with an overall survival of 16\u2009months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Xp11.2 RCC exhibits unique biological characteristics and is associated with an increased incidence of tumor thrombosis, lymph node metastasis, and advanced disease stages. Long-term follow-up is essential to monitor the likelihood of recurrence and metastasis. <jats:sup>18<\/jats:sup>F-FDG PET\/CT examination can comprehensively visualize the lesion\u2019s location and extent, providing a basis for clinical tumor staging and aiding in treatment monitoring and follow-up. To address the limitations of FDG, the utilization of specific tracers designed for RCC or tracers that are not excreted via the urinary system would be ideal. Further advancements in molecular imaging technologies and the development of novel tracers hold great promise in advancing the diagnosis and management of RCC, ultimately contributing to better patient outcomes and overall disease management.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1266630","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T04:34:35Z","timestamp":1695184475000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Multimodality imaging of Xp11.2 translocation\/TFE3 gene fusion associated with renal cell carcinoma: a case report"],"prefix":"10.3389","volume":"10","author":[{"given":"Wenpeng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushuo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur Urol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/01.pas.0000131558.32412.40","article-title":"Morphologic and molecular characterization of renal cell carcinoma in children and young adults","volume":"28","author":"Bruder","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e11023","DOI":"10.1097\/MD.0000000000011023","article-title":"Adult-onset renal cell carcinoma associated with Xp11.2 translocation\/TFE3 gene fusion: 3 case reports and review of literature","volume":"97","author":"Gong","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"ref5","volume-title":"WHO classification of tumours: Urinary and male genital tumours","year":"2022"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.32074\/1591-951X-814","article-title":"WHO 2022 classification of kidney tumors: what is relevant? An update and future novelties for the pathologist","volume":"115","author":"Cali\u00f2","year":"2022","journal-title":"Pathologica"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/s41379-021-00858-y","article-title":"Diagnostic utility of one-stop fusion gene panel to detect TFE3\/TFEB gene rearrangement and amplification in renal cell carcinomas","volume":"34","author":"Harada","year":"2021","journal-title":"Mod Pathol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41379-020-00713-6","article-title":"TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1","volume":"34","author":"Cali\u00f2","year":"2021","journal-title":"Mod Pathol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12894-016-0154-6","article-title":"Clinical characteristics of XP11.2 translocation\/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies","volume":"16","author":"Cheng","year":"2016","journal-title":"BMC Urol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1177\/1066896910375565","article-title":"Xp11.2 translocation renal cell carcinomas have a poorer prognosis than non-Xp11.2 translocation carcinomas in children and young adults: a meta-analysis","volume":"18","author":"Rao","year":"2010","journal-title":"Int J Surg Pathol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2478\/raon-2013-0077","article-title":"Xp 11.2 translocation renal carcinoma in young adults; recently classified distinct subtype","volume":"48","author":"Kmetec","year":"2014","journal-title":"Radiol Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jcma.2011.09.005","article-title":"XP11.2 translocation renal cell carcinoma: clinical experience of Taipei Veterans General Hospital","volume":"74","author":"Hung","year":"2011","journal-title":"J Chin Med Assoc"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/modpathol.2013.83","article-title":"Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases","volume":"27","author":"Hodge","year":"2014","journal-title":"Mod Pathol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e15793","DOI":"10.1371\/journal.pone.0015793","article-title":"Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization","volume":"5","author":"Hong","year":"2010","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0002-9440(10)61684-7","article-title":"Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents","volume":"159","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s10024-004-9106-3","article-title":"Pediatric renal carcinoma associated with Xp11.2 translocations\/TFE3 gene fusions and clinicopathologic associations","volume":"8","author":"Altinok","year":"2005","journal-title":"Pediatr Dev Pathol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.prp.2012.10.013","article-title":"Diagnosis of Xp11 translocation renal cell carcinomas in adult patients under 50 years: interest and pitfalls of automated immunohistochemical detection of TFE3 protein","volume":"209","author":"Gaillot-Durand","year":"2013","journal-title":"Pathol Res Pract"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1177\/0284185113484019","article-title":"Radiologic-pathologic correlation of renal cell carcinoma associated with Xp11.2 translocation","volume":"54","author":"Koo","year":"2013","journal-title":"Acta Radiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1309\/AJCPQ6LLFMC4OXGC","article-title":"Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis","volume":"137","author":"Klatte","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1158\/1078-0432.CCR-08-1183","article-title":"Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry","volume":"15","author":"Komai","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"109777","DOI":"10.1016\/j.ejrad.2021.109777","article-title":"The role of imaging in the management of renal masses","volume":"141","author":"Tsili","year":"2021","journal-title":"Eur J Radiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e99990","DOI":"10.1371\/journal.pone.0099990","article-title":"Magnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation\/TFE3 gene fusion","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1002\/jum.15951","article-title":"Contrast-enhanced ultrasound features of adult Xp11.2 translocation renal cell carcinoma: differential diagnosis with three main renal cell carcinoma subtypes","volume":"41","author":"Ma","year":"2022","journal-title":"J Ultrasound Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40644-019-0268-7","article-title":"Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation\/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma","volume":"20","author":"Wei","year":"2019","journal-title":"Cancer Imaging"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/jmri.24349","article-title":"Renal carcinomas associated with Xp11.2 translocations\/TFE3 gene fusions: findings on MRI and computed tomography imaging","volume":"40","author":"Liu","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/RCT.0000000000000263","article-title":"Dynamic computed tomographic features of adult renal cell carcinoma associated with Xp11.2 translocation\/TFE3 gene fusions: comparison with clear cell renal cell carcinoma","volume":"39","author":"He","year":"2015","journal-title":"J Comput Assist Tomogr"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4103\/jcrt.jcrt_1505_22","article-title":"Imaging findings, clinical and pathological characters of 28 patients with Xp11.2\/TFE3 translocation renal cell carcinoma","volume":"19","author":"Dong","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1245\/s10434-020-08813-y","article-title":"Nephron-sparing surgery for adult Xp11.2 translocation renal cell carcinoma at clinical T1 stage: a multicenter study in China","volume":"28","author":"Liu","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1258\/ar.2012.120255","article-title":"The multislice CT findings of renal carcinoma associated with XP11.2 translocation\/TFE gene fusion and collecting duct carcinoma","volume":"54","author":"Zhu","year":"2013","journal-title":"Acta Radiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00330-016-4421-4","article-title":"Renal cell carcinoma associated with Xp11.2 translocation\/TFE gene fusion: imaging findings in 21 patients","volume":"27","author":"Chen","year":"2017","journal-title":"Eur Radiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00261-018-1703-0","article-title":"Magnetic resonance imaging findings of renal cell carcinoma associated with Xp11.2 translocation\/TFE3 gene fusion in adults: a pilot study","volume":"44","author":"Dai","year":"2019","journal-title":"Abdom Radiol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1479-5876-11-15","article-title":"Vascularity of primary and metastatic renal cell carcinoma specimens","volume":"11","author":"Aziz","year":"2013","journal-title":"J Transl Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/RLU.0000000000000875","article-title":"Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET\/CT","volume":"40","author":"Takahashi","year":"2015","journal-title":"Clin Nucl Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00432-022-03958-7","article-title":"Role of PSMA-ligands imaging in renal cell carcinoma management: current status and future perspectives","volume":"148","author":"Urso","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s00259-021-05596-6","article-title":"68Ga-EMP-100 PET\/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging results","volume":"49","author":"Mittlmeier","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1097\/RLU.0000000000003053","article-title":"68Ga-PSMA PET\/CT and 18F-FDG PET\/CT in renal cell carcinoma","volume":"45","author":"Chen","year":"2020","journal-title":"Clin Nucl Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.eururo.2018.04.026","article-title":"Positron emission tomography\/computed tomography with 89Zr-girentuximab can aid in diagnostic dilemmas of clear cell renal cell carcinoma suspicion","volume":"74","author":"Hekman","year":"2018","journal-title":"Eur Urol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/annonc\/mds463","article-title":"C-met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma","volume":"24","author":"Gibney","year":"2013","journal-title":"Ann Oncol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pathol.2019.11.006","article-title":"Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets","volume":"52","author":"Cali\u00f2","year":"2020","journal-title":"Pathology"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/jjco\/29.4.198","article-title":"Alveolar architecture of clear cell renal carcinomas (< or = 5.0 cm) show high attenuation on dynamic CT scanning","volume":"29","author":"Fujimoto","year":"1999","journal-title":"Jpn J Clin Oncol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1148\/radiol.13112617","article-title":"Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT","volume":"267","author":"Young","year":"2013","journal-title":"Radiology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00330-007-0757-0","article-title":"MR classification of renal masses with pathologic correlation","volume":"18","author":"Pedrosa","year":"2008","journal-title":"Eur Radiol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1148\/rg.274065147","article-title":"Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation","volume":"27","author":"Silverman","year":"2007","journal-title":"Radiographics"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1200\/JCO.2008.21.7034","article-title":"Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma","volume":"27","author":"Rini","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11604-010-0450-0","article-title":"Magnetic resonance imaging of large chromophobe renal cell carcinomas","volume":"28","author":"Sasaguri","year":"2010","journal-title":"Jpn J Radiol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"151908","DOI":"10.1016\/j.anndiagpath.2022.151908","article-title":"Renal cancer associated with Xp11.2 translocation\/TFE3 gene fusion: Clinicopathological analysis of 13 cases","volume":"58","author":"Feng","year":"2022","journal-title":"Ann Diagn Pathol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"826325","DOI":"10.3389\/fonc.2021.826325","article-title":"Case report: TFE3 positive Xp11.2 translocation renal cell carcinoma (TRCC) - a case study and review of the literature. Front","volume":"11","author":"Miro\u0144ski","year":"2021","journal-title":"Oncologia"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/810590","article-title":"Renal cell carcinoma associated with Xp11.2 translocation\/TFE3 gene fusion: a rare case report with review of the literature","volume":"2013","author":"Ahluwalia","year":"2013","journal-title":"Case Rep Urol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jpedsurg.2013.10.005","article-title":"Biological characteristics of pediatric renal cell carcinoma associated with Xp11.2 translocations\/TFE3 gene fusions","volume":"49","author":"Song","year":"2014","journal-title":"J Pediatr Surg"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"610360","DOI":"10.3389\/pore.2021.610360","article-title":"Factors associated with survival from Xp11.2 translocation renal cell carcinoma diagnosis-a systematic review and pooled analysis","volume":"27","author":"Wu","year":"2021","journal-title":"Pathol Oncol Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10147-010-0154-6","article-title":"A case study of metastatic Xp11.2 translocation renal cell carcinoma effectively treated with sunitinib","volume":"16","author":"Numakura","year":"2011","journal-title":"Int J Clin Oncol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1309\/LR5G1VMXPY3G0CUK","article-title":"Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults","volume":"128","author":"Meyer","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e0166897","DOI":"10.1371\/journal.pone.0166897","article-title":"Renal cell carcinoma associated with Xp11.2 translocation\/TFE3 gene fusions: clinical features, treatments and prognosis","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1266630\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T04:34:39Z","timestamp":1695184479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1266630\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":53,"alternative-id":["10.3389\/fmed.2023.1266630"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1266630","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"article-number":"1266630"}}